Cancer Treatment Reviews
Volume 29, Issue 5 , Pages 407-415 , October 2003

Mode of action of docetaxel – a basis for combination with novel anticancer agents

  • Roy S Herbst

      Affiliations

    • Department of Thoracic/Head and Neck Medical Oncology and Cancer Biology, The University of Texas, Houston, TX, USA
    • ,
  • Fadlo R Khuri

      Affiliations

    • Clinical and Translational Research, Emory University, Atlanta, GA, USA
    • Corresponding Author InformationCorrespondence to: Professor Fadlo R. Khuri, MD, Associate Director, Clinical and Translational Research, Winship Cancer Center, Emory University, 1365 Clifton Road, Suite B4100 Atlanta, GA 30322, USA

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.

PII: S0305-7372(03)00097-5

doi: 10.1016/S0305-7372(03)00097-5

Cancer Treatment Reviews
Volume 29, Issue 5 , Pages 407-415 , October 2003

Article Tools

* Image Usage & Resolution